49 results on '"Michal Lipinski"'
Search Results
2. Loss of Kdm5c Causes Spurious Transcription and Prevents the Fine-Tuning of Activity-Regulated Enhancers in Neurons
- Author
-
Marilyn Scandaglia, Jose P. Lopez-Atalaya, Alejandro Medrano-Fernandez, Maria T. Lopez-Cascales, Beatriz del Blanco, Michal Lipinski, Eva Benito, Roman Olivares, Shigeki Iwase, Yang Shi, and Angel Barco
- Subjects
intellectual disability ,Claes-Jensen syndrome ,lysine demethylase 5C ,histone methylation ,spurious transcription ,germline gene silencing ,immediate early gene ,enhancer ,epigenetic repression ,DNA methylation ,Biology (General) ,QH301-705.5 - Abstract
During development, chromatin-modifying enzymes regulate both the timely establishment of cell-type-specific gene programs and the coordinated repression of alternative cell fates. To dissect the role of one such enzyme, the intellectual-disability-linked lysine demethylase 5C (Kdm5c), in the developing and adult brain, we conducted parallel behavioral, transcriptomic, and epigenomic studies in Kdm5c-null and forebrain-restricted inducible knockout mice. Together, genomic analyses and functional assays demonstrate that Kdm5c plays a critical role as a repressor responsible for the developmental silencing of germline genes during cellular differentiation and in fine-tuning activity-regulated enhancers during neuronal maturation. Although the importance of these functions declines after birth, Kdm5c retains an important genome surveillance role preventing the incorrect activation of non-neuronal and cryptic promoters in adult neurons.
- Published
- 2017
- Full Text
- View/download PDF
3. Tracking Dynamical Features via Continuation and Persistence.
- Author
-
Tamal K. Dey, Michal Lipinski, Marian Mrozek, and Ryan Slechta
- Published
- 2022
- Full Text
- View/download PDF
4. Persistence Bag-of-Words for Topological Data Analysis.
- Author
-
Bartosz Zielinski 0001, Michal Lipinski, Mateusz Juda, Matthias Zeppelzauer, and Pawel Dlotko
- Published
- 2019
- Full Text
- View/download PDF
5. Deep learning and alignment of spatially resolved single-cell transcriptomes with Tangram
- Author
-
Aman Sanger, Ayshwarya Subramanian, Ziqing Lu, Raghav Avasthi, Nik Bear Brown, Evan Z. Macosko, Asa Segerstolpe, Mor Nitzan, Aviv Regev, Gabriele Scalia, Inbal Avraham-Davidi, Tommaso Biancalani, Neriman Tokcan, Meng Zhang, Xiaowei Zhuang, Sai Ma, Duccio Fanelli, Michal Lipinski, Jason D. Buenrostro, Sanja Vickovic, Charles R. Vanderburg, and Lorenzo Buffoni
- Subjects
Computer science ,business.industry ,Deep learning ,Multimodal data ,Spatially resolved ,genetic processes ,Pattern recognition ,Cell Biology ,Brain tissue ,Biochemistry ,Spatial ecology ,Spatial maps ,Artificial intelligence ,Scale (map) ,business ,Molecular Biology ,Spatial analysis ,Biotechnology - Abstract
Charting an organs’ biological atlas requires us to spatially resolve the entire single-cell transcriptome, and to relate such cellular features to the anatomical scale. Single-cell and single-nucleus RNA-seq (sc/snRNA-seq) can profile cells comprehensively, but lose spatial information. Spatial transcriptomics allows for spatial measurements, but at lower resolution and with limited sensitivity. Targeted in situ technologies solve both issues, but are limited in gene throughput. To overcome these limitations we present Tangram, a method that aligns sc/snRNA-seq data to various forms of spatial data collected from the same region, including MERFISH, STARmap, smFISH, Spatial Transcriptomics (Visium) and histological images. Tangram can map any type of sc/snRNA-seq data, including multimodal data such as those from SHARE-seq, which we used to reveal spatial patterns of chromatin accessibility. We demonstrate Tangram on healthy mouse brain tissue, by reconstructing a genome-wide anatomically integrated spatial map at single-cell resolution of the visual and somatomotor areas.
- Published
- 2021
- Full Text
- View/download PDF
6. Rifaximin in gut microbiota modification in acute pancreatitis: 15 years of retrospective clinical study
- Author
-
Jacek Tatur, Michal Lipinski, Marta Sznurkowska, Ewa Jozefik, and Grazyna Rydzewska
- Subjects
Medicine (miscellaneous) ,Middle Aged ,Severity of Illness Index ,General Biochemistry, Genetics and Molecular Biology ,Rifaximin ,Gastrointestinal Microbiome ,Pancreatitis ,Reviews and References (medical) ,Acute Disease ,Internal Medicine ,Humans ,Pharmacology (medical) ,Genetics (clinical) ,Retrospective Studies - Abstract
Gut decontamination could have some benefits in preventing infectious complications in acute pancreatitis (AP).To investigate whether the administration of rifaximin could have an impact on the outcomes of AP.We conducted a retrospective study on 373 patients with a median age of 50 years that were admitted to our Department of Gastroenterology in the years 2001-2016 with a diagnosis of AP. Patients were subclassified according to the revised Atlanta criteria: mild acute pancreatitis (MAP), moderately severe acute pancreatitis (MSAP) and severe acute pancreatitis (SAP). Thereafter, all the patients were divided into 2 groups: in the 1st group (R0) with MSAP and SAP, patients did not receive rifaximin, and in the 2nd group (R1), in the cases of MSAP and SAP, rifaximin was administered to patients at a dose of 3 × 400 mg (for at least 5 days and up to 7 days). There was no other difference in the treatment between the groups. The median duration of hospital stay, the number of infectious complications and the mortality rate were recorded for both groups.A significant difference was observed between median durations of hospitalization between the groups with (R1) and without (R0) rifaximin treatment (14 days compared to 24 days, p = 0.001) and in the number of patients infected with pancreatic necrosis (7 compared to 1, p = 0.0487). However, there was no statistically significant difference between the R1 and R0 group in terms of mortality rate.The results indicate that rifaximin seems to be a promising novel therapeutic option in MSAP and SAP.
- Published
- 2022
7. Methods for prevention of acute post-endoscopic retrograde cholangiopancreatography pancreatitis
- Author
-
Kamil Jaszczuk, Michal Lipinski, and Grażyna Rydzewska
- Subjects
medicine.medical_specialty ,endoscopic retrograde cholangiopancreatography ,pancreatic duct stents ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,post-endoscopic retrograde cholangiopancreatography pancreatitis ,Pancreatic duct ,Review Paper ,nonsteroidal anti-inflammatory drugs ,Nonsteroidal ,Endoscopic retrograde cholangiopancreatography ,medicine.diagnostic_test ,business.industry ,Gastroenterology ,medicine.disease ,Surgery ,medicine.anatomical_structure ,chemistry ,030220 oncology & carcinogenesis ,Medicine ,Pancreatitis ,Acute pancreatitis ,030211 gastroenterology & hepatology ,Complication ,business - Abstract
Acute pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP), with incidence rates ranging between 2% and 16%. In addition to being experienced in endoscopic procedures and having knowledge of the patient qualification criteria, physicians should also be aware of the patient and procedure-related risk factors responsible for post-ERCP pancreatitis (PEP). Intrarectal administration of nonsteroidal anti-inflammatory drugs and pancreatic duct stenting were demonstrated to be efficient in high-risk patients. This review provides a broader summary of pharmacological methods and techniques aimed at reducing the risk of PEP.
- Published
- 2020
8. KAT3-dependent acetylation of cell type-specific genes maintains neuronal identity in the adult mouse brain
- Author
-
Román Olivares, Juan Medrano-Relinque, Angel Barco, Rafael Muñoz-Viana, Grzegorz M. Wilczynski, Angel Marquez-Galera, Santiago Canals, Carmen M. Navarrón, Jordi Fernandez-Albert, Beatriz del Blanco, José P. López-Atalaya, Michal Lipinski, José M. Caramés, Andrzej A. Szczepankiewicz, Ministerio de Ciencia, Innovación y Universidades (España), Ministerio de Economía y Competitividad (España), Agencia Estatal de Investigación (España), European Commission, Generalitat Valenciana, Polish Academy of Sciences, Ministerio de Educación, Cultura y Deporte (España), Lipinski, Michal [0000-0001-8200-5056], Muñoz-Viana, Rafael [0000-0002-1363-6978], Szczepankiewicz, Andrzej A. [0000-0002-1502-3147], Navarrón, Carmen M. [0000-0002-6304-3695], Canals Gamoneda, Santiago [0000-0003-2175-8139], Barco, Ángel [0000-0002-0653-3751], Lipinski, Michal, Muñoz-Viana, Rafael, Szczepankiewicz, Andrzej A., Navarrón, Carmen M., Canals Gamoneda, Santiago, and Barco, Ángel
- Subjects
Male ,0301 basic medicine ,Epigenetic memory ,Science ,General Physics and Astronomy ,Biology ,Article ,General Biochemistry, Genetics and Molecular Biology ,Epigenome ,03 medical and health sciences ,0302 clinical medicine ,Gene expression ,Basic Helix-Loop-Helix Transcription Factors ,Animals ,p300-CBP Transcription Factors ,Epigenetics in the nervous system ,lcsh:Science ,Enhancer ,Transcription factor ,Gene ,Mice, Knockout ,Neurons ,Multidisciplinary ,Transdifferentiation ,Brain ,Membrane Proteins ,Acetylation ,Promoter ,General Chemistry ,Lysine Acetyltransferases ,Phosphoproteins ,Cell biology ,Enhancer Elements, Genetic ,030104 developmental biology ,Histone ,Gene Expression Regulation ,nervous system ,biology.protein ,Female ,lcsh:Q ,030217 neurology & neurosurgery - Abstract
The lysine acetyltransferases type 3 (KAT3) family members CBP and p300 are important transcriptional co-activators, but their specific functions in adult post-mitotic neurons remain unclear. Here, we show that the combined elimination of both proteins in forebrain excitatory neurons of adult mice resulted in a rapidly progressing neurological phenotype associated with severe ataxia, dendritic retraction and reduced electrical activity. At the molecular level, we observed the downregulation of neuronal genes, as well as decreased H3K27 acetylation and pro-neural transcription factor binding at the promoters and enhancers of canonical neuronal genes. The combined deletion of CBP and p300 in hippocampal neurons resulted in the rapid loss of neuronal molecular identity without de- or transdifferentiation. Restoring CBP expression or lysine acetylation rescued neuronal-specific transcription in cultured neurons. Together, these experiments show that KAT3 proteins maintain the excitatory neuron identity through the regulation of histone acetylation at cell type-specific promoter and enhancer regions., M.L. is recipient of a Santiago Grisolia fellowship given by the Generalitat Valenciana, J.M.C. is recipient of a fellowship from the Spanish Ministry of Education, Culture and Sport (MECD), J.F.-A. and C.M.N. are recipients of fellowships from the Spanish Ministry of Science and Innovation (MICINN). The ultrastructure research was supported by the Polish National Science Center Grant UMO-2014/15/N/NZ3/04468 and by the European Regional Development Fund POIG 01.01.02-00-008/08. J.P.L.-A. research is supported by Grants RYC-2015-18056 and RTI2018-102260-B-I00 from MICINN co-financed by ERDF. A.B. research is supported by Grants SAF2017-87928-R, PCIN-2015-192-C02-01, and SEV-2017-0723 from MICINN co-financed by ERDF, PROMETEO/2016/026 from the Generalitat Valenciana, and RGP0039/2017 from the Human Frontiers Science Program Organization (HFSPO). The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa”.
- Published
- 2020
9. CBP is required for establishing adaptive gene programs in the adult mouse brain
- Author
-
Michal Lipinski, Sergio Niñerola, Miguel Fuentes-Ramos, Luis M. Valor, Beatriz del Blanco, Jose P. López-Atalaya, Angel Barco, Generalitat Valenciana, Ministerio de Ciencia e Innovación (España), Instituto de Salud Carlos III, European Commission, Ministerio de Educación (España), Fundación Tatiana Pérez de Guzmán el Bueno, Fundació La Marató de TV3, Human Frontier Science Program, Ministerio de Ciencia, Innovación y Universidades (España), and Agencia Estatal de Investigación (España)
- Subjects
Male ,General Neuroscience ,Intellectual disability ,Acetylation ,p300 ,Neuroepigenetics ,CBP ,CREB-Binding Protein ,Hippocampus ,Chromatin ,Epigenesis, Genetic ,Histones ,Mice ,Activity-driven transcription ,Animals ,Female ,p300-CBP Transcription Factors ,Lysine acetylation ,Histone Acetyltransferases ,Transcription Factors - Abstract
Environmental factors and life experiences impinge on brain circuits triggering adaptive changes. Epigenetic regulators contribute to this neuroadaptation by enhancing or suppressing specific gene programs. The paralogous transcriptional coactivators and lysine acetyltransferases CREB binding protein (CBP) and p300 are involved in brain plasticity and stimulus-dependent transcription, but their specific roles in neuroadaptation are not fully understood. Here we investigated the impact of eliminating either CBP or p300 in excitatory neurons of the adult forebrain of mice from both sexes using inducible and cell type-restricted knock-out strains. The elimination of CBP, but not p300, reduced the expression and chromatin acetylation of plasticity genes, dampened activity-driven transcription, and caused memory deficits. The defects became more prominent in elderly mice and in paradigms that involved enduring changes in transcription, such as kindling and environmental enrichment, in which CBP loss interfered with the establishment of activity-induced transcriptional and epigenetic changes in response to stimulus or experience. These findings further strengthen the link between CBP deficiency in excitatory neurons and etiopathology in the nervous system., M.L. was the recipient of a Santiago Grisolia fellowship from Generalitat Valenciana. S.N. is the recipient of an FPI Pre-Doctoral Fellowship from the Spanish Ministry of Science and Innovation (MICINN). M.F.-R. is the recipient of an FPU-PhD Fellowship from the Spanish Ministry of Education. L.M.V. is the recipient of Miguel Servet II Contract CPII20/00025 from Instituto de Salud Carlos III (ISCIII) and the European Social Fund. A.B. research is supported by Grant 202003 from Fundación Tatiana Pérez de Guzmán el Bueno and Fundació la Marató de TV3; Grant PID2020-118169RB-100 from the Ministry of Science and Innovation cofinanced by the European Regional Development Fund (ERDF); Grant PROMETEO/2020/007 from the Generalitat Valenciana; and Grant RGP0039/2017 from the Human Frontiers Science Program Organization. L.M.V. research is supported by Grant PI19/00125 from Instituto de Salud Carlos III and the ERDF. J.P.L.-A. research is funded by grants from MICIU cofinanced by ERDF (Grant RTI2018-102260-B-I00), and Generalitat Valenciana (Grant PROMETEO/2020/007). The Instituto de Neurociencias is funded by “Centre of Excellence Severo Ochoa” Grant SEV-2017-0723.
- Published
- 2022
10. Guidelines on the management of irritable bowel syndrome
- Author
-
Jaroslaw Regula, Ewa Małecka-Panas, Barbara Skrzydło-Radomańska, Agata Mulak, Michal Lipinski, Anna Pietrzak, and Grażyna Rydzewska
- Subjects
diastolic drugs ,medicine.medical_specialty ,loperamide ,media_common.quotation_subject ,lcsh:Medicine ,Scientific language ,03 medical and health sciences ,Presentation ,chemistry.chemical_compound ,0302 clinical medicine ,macrogols ,IBS ,Epidemiology ,medicine ,Acronym ,guidelines ,Irritable bowel syndrome ,media_common ,irritable bowel syndrome ,business.industry ,Task force ,lcsh:R ,Gastroenterology ,rifaximin ,medicine.disease ,Rifaximin ,chemistry ,030220 oncology & carcinogenesis ,Family medicine ,antidepressants ,recommendations ,Etiology ,030211 gastroenterology & hepatology ,business ,IBS treatment - Abstract
In memory of Professor Witold Bartnik These guidelines constitute an update of the previous „Recommendations on the management of irritable bowel syndrome” issued in 2008. They have been developed by a Task Force organized by the Governing Board of the Polish Society of Gastroenterology. They discuss, with particular emphasis on new scientific data covering papers published since 2008: the etiology, epidemiology, clinical presentation, diagnostic principles and criteria for the diagnosis, and recommendations for the treatment of irritable bowel syndrome (IBS). The English-language acronym for the syndrome (IBS) has become popular in medical and popular scientific language, it is also widely recognized by patients who identify with this diagnosis. Therefore, in the discussed guidelines, this is what we will use.
- Published
- 2018
11. Diagnostic and therapeutic recommendations for chronic pancreatitis. Recommendations of the Working Group of the Polish Society of Gastroenterology and the Polish Pancreas Club
- Author
-
Mirosław Jarosz, Michal Lipinski, Anita Gąsiorowska, Krystian Adrych, Grażyna Rydzewska, Marek Durlik, Ewa Małecka-Panas, Grażyna Jurkowska, Roland Kadaj-Lipka, Mariusz Rosołowski, Grzegorz Oracz, Barbara Skrzydło-Radomańska, and Renata Talar-Wojnarowska
- Subjects
0301 basic medicine ,Polish Pancreas Club ,medicine.medical_specialty ,endoscopic treatment ,surgical treatment ,pancreatic cancer ,MEDLINE ,lcsh:Medicine ,Gastroenterology ,Surgical methods ,chronic pancreatitis ,03 medical and health sciences ,enzymatic replacement therapy ,Internal medicine ,medicine ,guidelines ,Autoimmune pancreatitis ,business.industry ,lcsh:R ,endosonography ,medicine.disease ,Expert group ,humanities ,Clinical trial ,Polish Society of Gastroenterology ,030104 developmental biology ,Pancreatitis ,Observational study ,Club ,Special Paper ,business - Abstract
This article describes the latest diagnostic and therapeutic recommendations in chronic pancreatitis, developed by the Working Group of the Polish Society of Gastroenterology and the Polish Pancreas Club. The recommendations refer to the diagnosis of chronic pancreatitis, autoimmune pancreatitis, conservative management, treatment of pain, and exocrine and endocrine pancreatic insufficiency, treatment of chronic pancreatitis by endoscopic and surgical methods, and oncological surveillance of chronic pancreatitis. This paper refers to the Polish recommendations published in 2011, which have been updated and supplemented. All recommendations were voted by experts of the Polish Society of Gastroenterology and the Polish Pancreas Club, who evaluated them each time on a five‑degree scale, where I meant full acceptance, II – acceptance with some reservation, III – acceptance with serious reservation, IV – rejection with some reservation and V – full rejection. The results of the voting, together with a brief commentary, have been included with each recommendation put to the vote. In addition, the expert group assessed the value of clinical studies on which the statements are based, on a scale where A means high (based on meta‑analyses and randomised clinical trials), B means medium (based on clinical trials and observational studies), and C means low (based mainly on expert opinion).
- Published
- 2018
- Full Text
- View/download PDF
12. Loss of Kdm5c Causes Spurious Transcription and Prevents the Fine-Tuning of Activity-Regulated Enhancers in Neurons
- Author
-
Yang Shi, Román Olivares, Marilyn Scandaglia, José P. López-Atalaya, Beatriz del Blanco, Michal Lipinski, Alejandro Medrano-Fernandez, Shigeki Iwase, María T. Lopez-Cascales, Eva Benito, Angel Barco, Ministerio de Economía y Competitividad (España), European Commission, Generalitat Valenciana, Brain and Behavior Research Foundation, Fundación Alicia Koplowitz, and National Institutes of Health (US)
- Subjects
0301 basic medicine ,Doublecortin Domain Proteins ,Male ,Transcription, Genetic ,Cellular differentiation ,spurious transcription ,Histones ,Mice ,0302 clinical medicine ,lysine demethylase 5C ,lcsh:QH301-705.5 ,Epigenomics ,Genetics ,Histone Demethylases ,Mice, Knockout ,Neurons ,DNA methylation ,Gene Expression Regulation, Developmental ,Nuclear Proteins ,DNA-Binding Proteins ,Enhancer Elements, Genetic ,intellectual disability ,Female ,Microtubule-Associated Proteins ,Signal Transduction ,immediate early gene ,epigenetic repression ,Nerve Tissue Proteins ,Biology ,General Biochemistry, Genetics and Molecular Biology ,Article ,03 medical and health sciences ,germline gene silencing ,Prosencephalon ,Glial Fibrillary Acidic Protein ,Gene silencing ,Animals ,histone methylation ,Enhancer ,Maze Learning ,Gene ,Psychological repression ,Claes-Jensen syndrome ,Neuropeptides ,Oxidoreductases, N-Demethylating ,030104 developmental biology ,lcsh:Biology (General) ,Epigenetic Repression ,biology.protein ,Demethylase ,enhancer ,030217 neurology & neurosurgery - Abstract
During development, chromatin-modifying enzymes regulate both the timely establishment of cell-type-specific gene programs and the coordinated repression of alternative cell fates. To dissect the role of one such enzyme, the intellectual-disability-linked lysine demethylase 5C (Kdm5c), in the developing and adult brain, we conducted parallel behavioral, transcriptomic, and epigenomic studies in Kdm5c-null and forebrain-restricted inducible knockout mice. Together, genomic analyses and functional assays demonstrate that Kdm5c plays a critical role as a repressor responsible for the developmental silencing of germline genes during cellular differentiation and in fine-tuning activity-regulated enhancers during neuronal maturation. Although the importance of these functions declines after birth, Kdm5c retains an important genome surveillance role preventing the incorrect activation of non-neuronal and cryptic promoters in adult neurons., M.S. and A.M.-F. are recipients of “Formación de Personal Investigador” fellowships, and B.d.B. is the recipient of a “Juan de la Cierva – Incorporación” contract (all from the Spanish Ministry of Economy and Competitivity [MINECO]). J.P.L.-A.’s research is supported by a “Ramón y Cajal” contract and by grant SAF2014-60233-JIN from MINECO (co-financed by the European Regional Development Fund [ERDF]). A.B.’s research is supported by grants SAF2014-56197-R, PCIN-2015-192-C02-01 (part of the coordinated project ERA-Net NEURON8-2015), and SEV-2013-0317 from MINECO (co-financed by ERDF), grant PROMETEO/2016/006 from the Generalitat Valenciana, a NARSAD Independent Investigator grant (no. 21941) from the Brain & Behavior Research Foundation, and a grant from the Alicia Koplowitz Foundation. S.I.’s research is supported by NIH grant NS089896 and the Farrehi Family Foundation. KDM5C research in the Y.S. lab is supported by NIH grant MH096066. Y.S. is an American Cancer Society Research Professor. The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa.”
- Published
- 2017
13. Zalecenia ogólne dotyczące postępowania diagnostyczno-terapeutycznego w nowotworach neuroendokrynnych układu pokarmowego (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)
- Author
-
Anhelli Syrenicz, Robert Król, Aldona Kowalska, Alicja Hubalewska-Dydejczyk, Anna Nasierowska-Guttmejer, Agata Bałdys-Waligórska, Andrzej Szawłowski, Barbara Jarząb, Agnieszka Kolasińska-Ćwikła, Andrzej Cichocki, Marek Ruchała, Roman Junik, Jolanta Kunikowska, Paweł Lampe, Maciej Krzakowski, Lucyna Siemińska, Marek Bolanowski, Wanda Foltyn, Anna Sowa-Staszczak, Ewa Wachuła, Violetta Rosiek, Bogdan Marek, Krzysztof Sworczak, Grzegorz Kamiński, Joanna Pilch-Kowalczyk, Jolanta Blicharz-Dorniak, Magdalena Londzin-Olesik, Katarzyna Kuśnierz, Tomasz Bednarczuk, Leszek Królicki, Janusz Strzelczyk, Jarosław B. Ćwikła, Wojciech Zajęcki, Agnieszka Boratyn-Nowicka, Katarzyna Steinhof-Radwańska, Małgorzata Borowska, Anna Lewczuk-Myślicka, Dariusz Lange, Teresa Starzyńska, Michal Lipinski, Sergiusz Nawrocki, Massimo Falconi, Anna Zemczak, Daria Handkiewicz-Junak, Wojciech Zgliczyński, Andrzej Lewiński, Krzysztof Zieniewicz, Ewa Nowakowska-Duława, Beata Kos-Kudła, Dariusz Kajdaniuk, and Marek Szczepkowski
- Subjects
03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,business.industry ,030220 oncology & carcinogenesis ,Endocrinology, Diabetes and Metabolism ,Medicine ,030209 endocrinology & metabolism ,business - Published
- 2017
- Full Text
- View/download PDF
14. Nowotwory neuroendokrynne żołądka i dwunastnicy z uwzględnieniem gastrinoma (zasady postępowania rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)
- Author
-
Teresa Starzyńska, Katarzyna Steinhof-Radwańska, Roman Junik, Jolanta Kunikowska, Jolanta Blicharz-Dorniak, Beata Kos-Kudła, Anhelli Syrenicz, Krzysztof Sworczak, Aldona Kowalska, Violetta Rosiek, Bogdan Marek, Ewa Wachuła, Elzbieta Andrysiak-Mamos, Magdalena Londzin-Olesik, Anna Sowa-Staszczak, Robert Król, Grzegorz Kamiński, Tomasz Bednarczuk, Agnieszka Kolasińska-Ćwikła, Andrzej Szawłowski, Grażyna Rydzewska, Katarzyna Kuśnierz, Barbara Jarząb, Małgorzata Borowska, Wanda Foltyn, Marek Ruchała, Paweł Lampe, Wojciech Zajęcki, Agnieszka Boratyn-Nowicka, Anna Lewczuk-Myślicka, Jarosław B. Ćwikła, Janusz Strzelczyk, Massimo Falconi, Karolina Poczkaj, Dariusz Lange, Andrzej Cichocki, Anna Nasierowska-Guttmejer, Lucyna Siemińska, Marek Bolanowski, Michal Lipinski, Ewa Nowakowska-Duława, Alicja Hubalewska-Dydejczyk, Leszek Królicki, Agata Bałdys-Waligórska, Joanna Pilch-Kowalczyk, Dariusz Kajdaniuk, Marek Szczepkowski, Anna Zemczak, Daria Handkiewicz-Junak, Andrzej Lewiński, and Wojciech Zgliczyński
- Subjects
medicine.medical_specialty ,Gastrinoma ,Endocrinology ,business.industry ,Endocrinology, Diabetes and Metabolism ,General surgery ,medicine ,Medical diagnosis ,medicine.disease ,business ,Neuroendocrine tumour - Abstract
This paper presents the updated Polish Neuroendocrine Tumour Network expert panel recommendations on the management of neuroendocrine neoplasms (NENs) of the stomach and duodenum, including gastrinoma. The recommendations discuss the epidemiology, pathogenesis, and clinical presentation of these tumours as well as their diagnosis, including biochemical, histopathological, and localisation diagnoses. The principles of treatment are discussed, including endoscopic, surgical, pharmacological, and radionuclide treatments. Finally, there are also recommendations on patient monitoring.
- Published
- 2017
- Full Text
- View/download PDF
15. Nowotwory neuroendokrynne trzustki — zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)
- Author
-
Andrzej Cichocki, Agnieszka Kolasińska-Ćwikła, Joanna Pilch-Kowalczyk, Magdalena Londzin-Olesik, Andrzej Szawłowski, Lucyna Siemińska, Roman Junik, Barbara Jarząb, Anna Nasierowska-Guttmejer, Dariusz Kajdaniuk, Jolanta Kunikowska, Krzysztof Sworczak, Marek Szczepkowski, Marek Bolanowski, Paweł Lampe, Małgorzata Borowska, Marek Ruchała, Anna Lewczuk-Myślicka, Wojciech Zgliczyński, Robert Król, Bogdan Marek, Anhelli Syrenicz, Michał Jarząb, Wojciech Zajęcki, Agnieszka Boratyn-Nowicka, Wanda Foltyn, Tomasz Bednarczuk, Agata Bałdys-Waligórska, Jolanta Blicharz-Dorniak, Foltyn Handkiewicz-Junak, Anna Sowa-Staszczak, Aldona Kowalska, Grzegorz Kamiński, Katarzyna Kuśnierz, Teresa Starzyńska, Jarosław B. Ćwikła, Massimo Falconi, Alicja Hubalewska-Dydejczyk, Ewa Wachuła, Michal Lipinski, Leszek Królicki, Janusz Strzelczyk, Dariusz Lange, Katarzyna Steinhof-Radwańska, Anna Zemczak, Andrzej Lewiński, Ewa Nowakowska-Duława, Beata Kos-Kudła, and Violetta Rosiek
- Subjects
03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,business.industry ,030220 oncology & carcinogenesis ,Endocrinology, Diabetes and Metabolism ,Medicine ,030209 endocrinology & metabolism ,business - Published
- 2017
- Full Text
- View/download PDF
16. Nowotwory neuroendokrynne jelita cienkiego i wyrostka robaczkowego — zasady postępowania (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)
- Author
-
Andrzej Cichocki, Lucyna Siemińska, Massimo Falconi, Ewa Wachuła, Dariusz Kajdaniuk, Dariusz Lange, Marek Szczepkowski, Jolanta Blicharz-Dorniak, Ewa Nowakowska-Duława, Roman Junik, Wojciech Zajęcki, Agnieszka Boratyn-Nowicka, Jolanta Kunikowska, Janusz Strzelczyk, Magdalena Londzin-Olesik, Anhelli Syrenicz, Anna Nasierowska-Guttmejer, Katarzyna Steinhof-Radwańska, Katarzyna Kuśnierz, Marek Ruchala, Marek Bolanowski, Aldona Kowalska, Agnieszka Kolasińska-Ćwikła, Violetta Rosiek, A. Lewiński, Beata Kos-Kudła, Bogdan Marek, Jakub Pałucki, Małgorzata Borowska, Wojciech Zgliczyński, Paweł Lampe, Anna Lewczuk-Myślicka, Leszek Królicki, Anna Zemczak, Daria Handkiewicz-Junak, Robert Król, Teresa Starzyńska, Krzysztof Sworczak, Grzegorz Kaminski, Tomasz Bednarczuk, Alicja Hubalewska-Dydejczyk, Joanna Pilch-Kowalczyk, Agata Bałdys-Waligórska, Michal Lipinski, Wanda Foltyn, Jarosław B. Ćwikła, Anna Sowa-Staszczak, Andrzej Szawłowski, and Barbara Jarząb
- Subjects
Enteroscopy ,Pathology ,medicine.medical_specialty ,biology ,business.industry ,Endocrinology, Diabetes and Metabolism ,Chromogranin A ,Ileum ,Neuroendocrine tumors ,medicine.disease ,Gastroenterology ,Appendicitis ,Appendix ,medicine.anatomical_structure ,Endocrinology ,Internal medicine ,medicine ,biology.protein ,Carcinoid Heart Disease ,business ,Carcinoid syndrome - Abstract
This study presents the revised Polish guidelines regarding the management of patients suffering from neuroendocrine neoplasms (NENs) of the small intestine and appendix. The small intestine, especially the ileum, is the most common location for these neoplasms. Most are well differentiated and slow growing. Their symptoms may be atypical, which can result in delayed or accidental diagnosis. Appendicitis is usually the first manifestation of NEN in this location. Typical symptoms of carcinoid syndrome occur in approximately 20-30% of patients suffering from small intestinal NENs with distant metastases. The main cause of death in patients with carcinoid syndrome is carcinoid heart disease. The most useful laboratory test is the determination of chromogranin A, while concentration of 5-hydroxyindoleacetic acid is helpful in the diagnostics of carcinoid syndrome. For visualisation, ultrasound, computed tomography, magnetic resonance imaging, colonoscopy, video capsule endoscopy, double-balloon enteroscopy, and somatostatin receptor scintigraphy may be used. A detailed his-tological report is crucial for the proper diagnostics and therapy of NENs of the small intestine and appendix. The treatment of choice is surgical management, either radical or palliative. The pharmacological treatment of the hormonally active and non-active small intestinal NENs as well as NENs of the appendix is based on long-acting somatostatin analogues. In patients with generalised NENs of the small intestine in progress during the SSA treatment, with good expression of somatostatin receptors, the first-line treatment should be radio-isotope therapy, while targeted therapies, such as everolimus, should be considered afterwards. When the above therapies are exhausted, in certain cases chemotherapy may be considered.
- Published
- 2017
- Full Text
- View/download PDF
17. Nowotwory neuroendokrynne jelita grubego — zasady postępowania (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)
- Author
-
Katarzyna Kuśnierz, Anna Nasierowska-Guttmejer, Jolanta Kunikowska, Grzegorz Kamiński, Massimo Falconi, Dariusz Kajdaniuk, Andrzej Cichocki, Paweł Lampe, Andrzej Szawłowski, Barbara Jarząb, Magdalena Londzin-Olesik, Bogdan Marek, Lucyna Siemińska, Marek Bolanowski, Andrzej Deptała, Marek Ruchała, Jolanta Blicharz-Dorniak, Joanna Pilch-Kowalczyk, Anna Zemczak, Daria Handkiewicz-Junak, Anhelli Syrenicz, Aldona Kowalska, Ewa Wachuła, Marek Szczepkowski, Krzysztof Sworczak, Wanda Foltyn, Agata Bałdys-Waligórska, Jarosław B. Ćwikła, Małgorzata Borowska, Agnieszka Kolasińska-Ćwikła, Andrzej Lewiński, Alicja Hubalewska-Dydejczyk, Dariusz Lange, Anna Sowa-Staszczak, Violetta Rosiek, Anna Lewczuk-Myślicka, Katarzyna Steinhof-Radwańska, Ewa Nowakowska-Duława, Wojciech Zgliczyński, Robert Król, Leszek Królicki, Michal Lipinski, Beata Kos-Kudła, Wojciech Zajęcki, Agnieszka Boratyn-Nowicka, Roman Junik, Teresa Starzyńska, Tomasz Bednarczuk, Janusz Strzelczyk, and Piotr Remiszewski
- Subjects
medicine.medical_specialty ,business.industry ,Endocrinology, Diabetes and Metabolism ,Poorly differentiated ,General surgery ,Rectum ,Neuroendocrine tumors ,Malignancy ,medicine.disease ,Gastroenterology ,Endocrinology ,medicine.anatomical_structure ,Internal medicine ,Epidemiology ,medicine ,Large intestine ,Good prognosis ,Surgical treatment ,business - Abstract
Neuroendocrine neoplasms/tumours (NENs/NETs) of the large intestine are detected increasingly often, especially rectal tumours, which is probably associated with the widespread use of screening colonoscopy. There is a growing body of evidence supporting the thesis that the NENs of the rectum and the NENs of the colon are two different diseases. Rectal NENs are usually small lesions, of low to moderate histological malignancy, associated with good prognosis, and most may be treated endoscopically. NENs of the colon, however, are often aggressive, poorly differentiated, associated with a poor or uncer-tain prognosis, and require surgical treatment. The management guidelines regarding these groups of patients are constantly changing. On the basis of the recent literature data and conclusions reached by the working meeting of the Polish Network of Neuroendocrine Tumours (December 2016), this study completes and updates the data and management guidelines regarding colorectal NENs published in Endokrynologia Polska 2013; 64: 358-368.
- Published
- 2017
- Full Text
- View/download PDF
18. Soluble urokinase-type plasminogen activator receptor (suPAR) in patients with acute pancreatitis (AP) - Progress in prediction of AP severity
- Author
-
Andrzej Rydzewski, Alicja Rydzewska-Rosołowska, Grażyna Rydzewska, Małgorzata Cicha, and Michal Lipinski
- Subjects
Adult ,Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Ischemia ,Inflammation ,Sensitivity and Specificity ,Severity of Illness Index ,Gastroenterology ,Receptors, Urokinase Plasminogen Activator ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,Prospective Studies ,Aged ,Aged, 80 and over ,Urokinase ,Hepatology ,business.industry ,Middle Aged ,Hypoxia (medical) ,medicine.disease ,Pancreatitis ,SuPAR ,030220 oncology & carcinogenesis ,Acute Disease ,Cohort ,Immunology ,Disease Progression ,Acute pancreatitis ,Female ,030211 gastroenterology & hepatology ,medicine.symptom ,business ,Plasminogen activator ,Biomarkers ,medicine.drug - Abstract
Background Soluble urokinase-type plasminogen activator receptor (suPAR) is a glycoprotein secreted during inflammation and infections. Moreover, increased levels of suPAR are observed after hypoxia and ischaemia. The aim of the study was to assess whether suPAR could represent a useful marker of acute pancreatitis (AP) severity. Patients and methods We have observed a cohort of 126 prospectively enrolled patients. Based on the presence of persistent organ failure (more than 48 h) and local complications (diagnosis of moderate AP [MSAP]), patients were classified into three groups: mild AP (MAP), moderate and severe AP (SAP). The blood samples were taken on admission for detecting suPAR concentrations. Results AP was considered severe in 33 patients (26.2%), MSAP was found in 37 patients (29.4%), and MAP was found in 56 patients (44,4%). The AUC for SAP predicted by suPAR was 0.993. The calculated cut-off point for prognosis SAP is 4.75 ng/mL. The BISAP score of ≥3 for detection of SAP had sensitivity and specificity of 94.6% and 63.6%, respectively. The AUC for severity predicted by BISAP amounted to 0.916. Additionally, suPAR turned out to be a good predictor of fatal AP: for the cut-off point 7.05 ng/mL, the AUC was 0.917. The AUC for death prediction in AP patients based on the BISAP score ≥3 was 0.894. Conclusions suPAR concentration is a promising new diagnostic and prognostic indicator in SAP obtainable in the early stage of disease. Larger studies are recommended to evaluate this role further.
- Published
- 2017
- Full Text
- View/download PDF
19. Immature granulocytes predict severe acute pancreatitis independently of systemic inflammatory response syndrome
- Author
-
Michal Lipinski and Grażyna Rydzewska
- Subjects
medicine.medical_specialty ,acute pancreatitis ,lcsh:Medicine ,Gastroenterology ,Pathogenesis ,03 medical and health sciences ,0302 clinical medicine ,immature granulocytes ,White blood cell ,Internal medicine ,medicine ,Intensive care medicine ,Automated analyser ,Whole blood ,Original Paper ,business.industry ,lcsh:R ,Area under the curve ,prediction ,medicine.disease ,Systemic inflammatory response syndrome ,systemic inflammatory response syndrome ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Acute pancreatitis ,Biomarker (medicine) ,030211 gastroenterology & hepatology ,business - Abstract
Introduction : Early prediction of severity of acute pancreatitis (AP) by a simple parameter that positively correlates with the activation stage of the immune system would be very helpful because it could influence the management and improve the outcome. Tumor necrosis factor α (TNF-α) and interleukin-1 (IL-1) play a critical role in the pathogenesis systemic inflammatory response syndrome (SIRS) and severity of AP. One of the effects of IL-1 and TNF-α is an increase in the number of immature granulocytes (IGs) in the peripheral blood. Aim : To assess whether the IGs% in plasma could be an independent marker of AP severity. Material and methods : A cohort of 77 patients with AP were prospectively enrolled in the study. The IGs were measured from whole blood samples obtained from the first day of hospitalization using an automated analyser. Results : We observed 44 (57%) patients with mild AP, 21 (27%) patients with moderate severe AP (SAP) and 12 (16%) patients with SAP. The cut-off value of IGs was 0.6%. The IGs > 0.6% had a sensitivity, specificity, and positive and negative predictive value of 100%, 96%, 85.7%, and 100%, respectively (area under the curve (AUC) = 0.98). On admission, SIRS was present in 25 (32%) patients. We found that in patients who fulfilled at least two criteria for SIRS, SAP could be predicted with 75% sensitivity and 75.4% specificity, positive predictive value 36%, negative predictive value 94.2%. Conclusions : The IGs% as a routinely obtained marker appears to be a promising, independent biomarker and a better predictor of early prognosis in SAP than SIRS and white blood cell.
- Published
- 2017
- Full Text
- View/download PDF
20. Neuronal identity is maintained in the adult brain through KAT3-dependent enhancer acetylation
- Author
-
Andrzej A. Szczepankiewicz, Angel Barco, Rafael Muñoz-Viana, Santiago Canals, Carmen M. Navarrón, Grzegorz M. Wilczynski, José P. López-Atalaya, Beatriz del Blanco, Román Olivares, Jordi Fernandez-Albert, Michal Lipinski, Juan Medrano-Relinque, José M. Caramés, and Angel Marquez-Galera
- Subjects
Cell type ,Lysine Acetyltransferases ,Acetylation ,Cellular differentiation ,Transdifferentiation ,Biology ,Enhancer ,Transcription factor ,Cell biology ,Chromatin - Abstract
Very little is known about the mechanisms responsible for maintaining cell identity in mature tissues. The paralogous type 3 lysine acetyltransferases (KAT3) CBP and p300 are both essential during development, but their specific functions in nondividing differentiated cells remains unclear. Here, we show that when both proteins are simultaneously knocked-out in excitatory neurons of the adult brain, the mice express a rapidly progressing neurological phenotype associated with reduced dendritic complexity and electrical activity, the transcriptional shutdown of neuronal genes, and a dramatic loss of H3K27 acetylation and pro-neural transcription factor binding at neuronal enhancers. The neurons lacking both KAT3 rapidly acquire a molecularly undefined fate with no sign of dedifferentiation, transdifferentiation or death. Restoring CBP expression or lysine acetylation reestablished neuronal-specific transcription. Our experiments demonstrate that KAT3 proteins act as fate-keepers in excitatory neurons and other cell types by jointly safeguarding chromatin acetylation levels at cell type-specific enhancers throughout life.
- Published
- 2019
- Full Text
- View/download PDF
21. Immediate and deferred epigenomic signature of neuronal activation
- Author
-
Beatriz del Blanco, Michal Lipinski, Ana M. Martin-Gonzalez, Victor G. Corces, M. Jordan Rowley, Angel Barco, Jordi Fernandez-Albert, and María T. Lopez-Cascales
- Subjects
0303 health sciences ,Hippocampal formation ,Biology ,Chromatin ,03 medical and health sciences ,0302 clinical medicine ,Transcription (biology) ,Neuroplasticity ,Enhancer ,Neuroscience ,Gene ,Transcription factor ,030217 neurology & neurosurgery ,030304 developmental biology ,Epigenomics - Abstract
SummaryActivity-driven transcription plays an important role in many brain processes, including those underlying memory and epilepsy. Here, we combine the genetic tagging of neuronal nuclei and ribosomes with various sequencing-based techniques to investigate the transcriptional and chromatin changes occurring at hippocampal excitatory neurons upon synchronous activation during status epilepticus and sparse activation during novel context exploration. The transcriptional burst, which affects both nucleus-resident non-coding RNAs and numerous protein-coding genes involved in neuroplasticity, is associated with a dramatic increase in chromatin accessibility of activity-regulated genes and enhancers,de novobinding of activity-regulated transcription factors, augmented promoter-enhancer interactions, and the formation of gene loops that bring together the TSS and TTS of strongly induced genes to sustain the fast re-loading of RNAPII complexes. Remarkably, some chromatin occupancy changes and interactions remain long after neuronal activation and may underlie the changes in neuronal responsiveness and circuit connectivity observed in these neuroplasticity paradigms.
- Published
- 2019
- Full Text
- View/download PDF
22. Immediate and deferred epigenomic signatures of in vivo neuronal activation in mouse hippocampus
- Author
-
M. Jordan Rowley, Angel Barco, Jordi Fernandez-Albert, Ana M. Martin-Gonzalez, Victor G. Corces, María T. Lopez-Cascales, Beatriz del Blanco, Michal Lipinski, Ministerio de Economía y Competitividad (España), Agencia Estatal de Investigación (España), Ministerio de Ciencia, Innovación y Universidades (España), European Commission, Generalitat Valenciana, Human Frontier Science Program, and National Institutes of Health (US)
- Subjects
0301 basic medicine ,Epigenomics ,Male ,Transcription, Genetic ,Biology ,Hippocampus ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,Status Epilepticus ,Transcription (biology) ,Seizures ,RNA polymerase ,Animals ,Enhancer ,Promoter Regions, Genetic ,Gene ,Transcription factor ,Genes, Immediate-Early ,Neurons ,Neuronal Plasticity ,General Neuroscience ,Chromatin ,3. Good health ,Mice, Inbred C57BL ,Transcription Factor AP-1 ,030104 developmental biology ,Enhancer Elements, Genetic ,chemistry ,Neuroscience ,Chromatin immunoprecipitation ,030217 neurology & neurosurgery - Abstract
Activity-driven transcription plays an important role in many brain processes, including those underlying memory and epilepsy. Here we combine genetic tagging of nuclei and ribosomes with RNA sequencing, chromatin immunoprecipitation with sequencing, assay for transposase-accessible chromatin using sequencing and Hi-C to investigate transcriptional and chromatin changes occurring in mouse hippocampal excitatory neurons at different time points after synchronous activation during seizure and sparse activation by novel context exploration. The transcriptional burst is associated with an increase in chromatin accessibility of activity-regulated genes and enhancers, de novo binding of activity-regulated transcription factors, augmented promoter–enhancer interactions and the formation of gene loops that bring together the transcription start site and transcription termination site of induced genes and may sustain the fast reloading of RNA polymerase complexes. Some chromatin occupancy changes and interactions, particularly those driven by AP1, remain long after neuronal activation and could underlie the changes in neuronal responsiveness and circuit connectivity observed in these neuroplasticity paradigms, perhaps thereby contributing to metaplasticity in the adult brain., J.F.-A. and M.T.L.-C. are recipients of fellowships from the Spanish Ministry of Science and Innovation (MICINN, SVP-2014-068387 and BES-2017-081298, respectively). The research of A.B. is supported by grants SAF2017-87928-R and SEV-2017-0723 from the MICINN co-financed by the ERDF, PROMETEO/2016/026 from the Generalitat Valenciana and RGP0039/2017 from the Human Frontiers Science Program Organization (HFSPO). M.J.R. is supported by the National Institutes of Health (NIH) Pathway to Independence Award K99/R00 GM127671. The research of V.G.C. is supported by the US Public Health Service Award (R01) GM035463 from the NIH. The content of the article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa”.
- Published
- 2019
- Full Text
- View/download PDF
23. Management of acute pancreatitis (AP) – Polish Pancreatic Club recommendations
- Author
-
Ewa Małecka-Panas, Paweł Lampe, Marek Dobosz, Magdalena Nowak-Niezgoda, Barbara Radomańska, Renata Talar-Wojnarowska, Katarzyna Kuśnierz, Grażyna Rydzewska, Stanisław Głuszek, Urszula Wereszczyńska-Siemiątkowska, Ewa Nowakowska-Duława, Mariusz Rosołowski, Michal Lipinski, and Marek Durlik
- Subjects
medicine.medical_specialty ,acute pancreatitis ,treatment ,business.industry ,Gastroenterology ,Reservation ,Disease ,medicine.disease ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,Current management ,030220 oncology & carcinogenesis ,Medicine ,Acute pancreatitis ,030211 gastroenterology & hepatology ,Club ,Special Paper ,business ,Intensive care medicine ,management - Abstract
The presented recommendations concern the current management of acute pancreatitis. The recommendations relate to the diagnostics and treatment of early and late phases of acute pancreatitis and complications of the disease taking into consideration surgical and endoscopic methods. All the recommendations were subjected to voting by the members of the Working Group of the Polish Pancreatic Club, who evaluated them every single time on a five-point scale, where A means full acceptance, B means acceptance with a certain reservation, C means acceptance with a serious reservation, D means rejection with a certain reservation and E means full rejection. The results of the vote, together with commentary, are provided for each recommendation.
- Published
- 2016
- Full Text
- View/download PDF
24. CBP/p300 in brain development and plasticity: disentangling the KAT's cradle
- Author
-
Michal Lipinski, Angel Barco, Beatriz del Blanco, Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), Ministerio de Economía y Competitividad (España), European Commission, Generalitat Valenciana, and Human Frontier Science Program
- Subjects
0301 basic medicine ,Nervous system ,Lysine Acetyltransferases ,General Neuroscience ,Lysine ,Brain ,Acetylation ,P300-CBP Transcription Factors ,Biology ,Cell biology ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,medicine.anatomical_structure ,Transcription (biology) ,Cbp p300 ,medicine ,Animals ,p300-CBP Transcription Factors ,Mode of action ,Neuroscience ,030217 neurology & neurosurgery - Abstract
The paralogous transcriptional co-activators CBP and p300 (aka KAT3A and KAT3B, respectively) contain a characteristic and promiscuous lysine acetyltransferase (KAT) domain and multiple independent protein-binding domains that enable them to interact with hundreds of proteins, possibly promoting the acetylation of thousands of target lysine residues. Both proteins play critical roles during the development of the nervous system and may also regulate stimuli-driven transcription and plasticity in postmitotic neurons. The multiplicity of functions, substrates, and molecular partners, together with the redundancy and singularity of the two KAT3 paralogs, define a complex cat’s cradle of relationships. In this review, we discuss the role of the KAT3 proteins in neurons and integrate recent information regarding their function and mode of action., A.B. research is supported by grants SAF2017-87928-R, PCIN-2015-192-C02-01 (part of the ERA-NET NEURON JTC2015 project ChromISyn) and SEV-2017-0723 from Ministerio de Ciencia, Innovación y Universidades (MICINN) co-financed by European Regional Development Fund (ERDF), PROMETEO/2016/026 from the Generalitat Valenciana, and RGP0039/2017 from the Human Frontiers Science Program Organization (HFSPO). The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa”.
- Published
- 2018
25. Autophosphorylation of alpha isoform of calcium/calmodulin-dependent kinase II regulates alcohol addiction-related behaviors
- Author
-
Zofia Mijakowska, Kasia Radwanska, Żaneta Matuszek, Kacper Łukasiewicz, Magda Ziółkowska, Anna Trąbczyńska, Szymon Łęski, and Michal Lipinski
- Subjects
0301 basic medicine ,Pharmacology ,Kinase ,business.industry ,Autophosphorylation ,Medicine (miscellaneous) ,Alpha (ethology) ,Hippocampus ,Amygdala ,03 medical and health sciences ,Psychiatry and Mental health ,Glutamatergic ,030104 developmental biology ,0302 clinical medicine ,medicine.anatomical_structure ,medicine ,Brain stimulation reward ,Threonine ,business ,Neuroscience ,030217 neurology & neurosurgery - Abstract
The development of addiction is associated with a dysregulation of glutamatergic transmission in the brain reward circuit. α isoform of calcium/calmodulin-dependent kinase II (αCaMKII) is one of the key proteins that regulates structural and functional plasticity of glutamatergic synapses. αCaMKII activity can be controlled by the autophosphorylation of threonine 286. The role of this autophosphorylation in the regulation of addiction-related behaviors has been proposed but is still poorly understood. Here, using αCaMKII autophosphorylation-deficient mutant mice (T286A), we show that, in comparison with wild-type animals, they are less resistant to high doses of alcohol and do not show psychostimulant response neither to alcohol injections nor during voluntary alcohol drinking. T286A mutants are also less prone to develop alcohol addiction-related behaviors including an increased motivation for alcohol, persistent alcohol seeking during withdrawal and alcohol consumption on relapse. Finally, we demonstrate that αCaMKII autophosphorylation regulates also alcohol-induced remodeling of glutamatergic synapses in the hippocampus and amygdala. In conclusion, our data suggest that αCaMKII autophosphorylation-dependent remodeling of glutamatergic synapses is a plausible mechanism for the regulation of the alcohol addiction-related behaviors.
- Published
- 2015
- Full Text
- View/download PDF
26. Skill Learning Modulates RNA Pol II Poising at Immediate Early Genes in the Adult Striatum
- Author
-
Rui M. Costa, Fernando J. Santos, Angel Barco, Michal Lipinski, and Pedro Galvão-Ferreira
- Subjects
Male ,Transcription, Genetic ,Protein subunit ,striatum ,motor skill ,RNA polymerase II ,Striatum ,RPB1 ,03 medical and health sciences ,0302 clinical medicine ,Transcription (biology) ,Transcriptional regulation ,RNA Pol II ,Animals ,Epigenetics ,Phosphorylation ,Gene ,Genes, Immediate-Early ,030304 developmental biology ,0303 health sciences ,learning ,biology ,General Neuroscience ,General Medicine ,New Research ,Corpus Striatum ,Mice, Inbred C57BL ,Gene Expression Regulation ,Motor Skills ,8.1 ,biology.protein ,Conditioning, Operant ,Sensory and Motor Systems ,RNA Polymerase II ,Neuroscience ,030217 neurology & neurosurgery - Abstract
A multilayered complexity of epigenetic and transcriptional regulatory mechanisms underlies neuronal activity-dependent gene transcription. The regulation of RNA Pol II progression along the transcription cycle, from promoter-proximal poising (with RNA Pol II paused at promoter-proximal regions, characterized by a Ser5P+-rich and Ser2P+-poor RPB1 CTD) to active elongation, has emerged as a major step in transcriptional regulation across several organisms, tissues, and developmental stages, including the nervous system. However, it is not known whether this mechanism is modulated by experience. We investigated the impact of learning a motor skill on RNA Pol II phosphorylation dynamics in the adult mouse striatum. We uncovered that learning modulates thein vivostriatal phosphorylation dynamics of the CTD of the RNA Pol II RPB1 subunit, leading to an increased poising index in trained mice. We found that this modulation occurs at immediate early genes (IEGs), with increased poising of RNA Pol II at bothArcandFosgenes but not at constitutively expressed genes. Furthermore, we confirmed that this was learning dependent, and not just regulated by context or motor activity. These experiments demonstrate a novel phenomenon of learning induced transcriptional modulation in adult brain, which may have implications for our understanding of learning, memory allocation, and consolidation.
- Published
- 2017
27. Zalecenia ogólne dotyczące postępowania w nowotworach neuroendokrynnych układu pokarmowego (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)
- Author
-
Małgorzata Borowska, Tomasz Bednarczuk, Agnieszka Kolasińska-Ćwikła, Violetta Rosiek, Magdalena Londzin-Olesik, Wojciech Zgliczyński, Jolanta Kunikowska, Katarzyna Kuśnierz, Andrzej Lewiński, Anna Zemczak, Daria Handkiewicz-Junak, Agata Bałdys-Waligórska, Krzysztof Zieniewicz, Ewa Nowakowska-Duława, Roman Junik, Wojciech Zajęcki, Agnieszka Boratyn-Nowicka, Bogdan Marek, Marek Bolanowski, Jolanta Blicharz-Dorniak, Andrzej Cichocki, Dariusz Lange, Anna Lewczuk-Myślicka, Alicja Hubalewska-Dydejczyk, Anna Nasierowska-Guttmejer, Andrzej Szawłowski, Anhelli Syrenicz, Maciej Krzakowski, Beata Kos-Kudła, Lucyna Siemińska, Joanna Pilch-Kowalczyk, Aldona Kowalska, Barbara Jarząb, Paweł Lampe, Grzegorz Kamiński, Janusz Strzelczyk, Michal Lipinski, Robert Król, Marek Ruchała, Wanda Foltyn, Anna Sowa-Staszczak, Jarosław B. Ćwikła, Leszek Królicki, Sergiusz Nawrocki, Massimo Falconi, Ewa Wachuła, Teresa Starzyńska, Katarzyna Steinhof-Radwańska, Dariusz Kajdaniuk, Marek Szczepkowski, and Krzysztof Sworczak
- Subjects
medicine.medical_specialty ,Gastrinoma ,business.industry ,Endocrinology, Diabetes and Metabolism ,General surgery ,Gastro entero pancreatic ,Neuroendocrine tumors ,medicine.disease ,Gastroenterology ,Optimal management ,Neuroendocrine tumour ,Clinical trial ,Endocrinology ,Round table ,Internal medicine ,medicine ,Neoplasm staging ,business - Abstract
Progress in the diagnostics and therapy of gastro-entero-pancreatic (GEP) neuroendocrine neoplasms (NEN), the published results of new randomised clinical trials, and the new guidelines issued by the European Neuroendocrine Tumour Society (ENETS) have led the Polish Network of Neuroendocrine Tumours to update the 2013 guidelines regarding management of these neoplasms. We present the general recommendations for the management of NENs, developed by experts during the Third Round Table Conference - Diagnostics and therapy of gastro-entero-pancreatic neuroendocrine neoplasms: Polish recommendations in view of current European recommenda-tions, which took place in December 2016 in Żelechow near Warsaw. Drawing from the extensive experience of centres dealing with this type of neoplasms, we hope that we have managed to develop the optimal management system, applying the most recent achievements in the field of medicine, for these patients, and that it can be implemented effectively in Poland. These management guidelines have been arranged in the following order: gastric and duodenal NENs (including gastrinoma); pancreatic NENs; NENs of the small intestine and appendix, and colorectal NENs.
- Published
- 2014
- Full Text
- View/download PDF
28. Nowotwory neuroendokrynne trzustki — zasady postępowania (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)
- Author
-
Agata Bałdys-Waligórska, Roman Junik, Michał Jarząb, Marek Bolanowski, Wanda Foltyn, Małgorzata Borowska, Grzegorz Kamiński, Massimo Falconi, Krzysztof Sworczak, Anna Sowa-Staszczak, Andrzej Lewiński, Jarosław B. Ćwikła, Wojciech Zgliczyński, Wojciech Zajęcki, Agnieszka Boratyn-Nowicka, Magdalena Londzin-Olesik, Andrzej Szawłowski, Jolanta Kunikowska, Barbara Jarząb, Dariusz Kajdaniuk, Ewa Nowakowska-Duława, Anna Lewczuk-Myślicka, Anna Nasierowska-Guttmejer, Tomasz Bednarczuk, Michal Lipinski, Marek Ruchała, Joanna Pilch-Kowalczyk, Katarzyna Steinhof-Radwańska, Andrzej Cichocki, Bogdan Marek, Lucyna Siemińska, Marek Szczepkowski, Anna Zemczak, Ewa Wachuła, Teresa Starzyńska, Violetta Rosiek, Paweł Lampe, Dariusz Lange, Katarzyna Kuśnierz, Beata Kos-Kudła, Janusz Strzelczyk, Robert Król, Foltyn Handkiewicz-Junak, Alicja Hubalewska-Dydejczyk, Anhelli Syrenicz, Aldona Kowalska, Jolanta Blicharz-Dorniak, Leszek Królicki, and Agnieszka Kolasińska-Ćwikła
- Subjects
Chemotherapy ,Pathology ,medicine.medical_specialty ,Peptide receptor ,business.industry ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Non functional ,MEDLINE ,Multidisciplinary team ,Targeted therapy ,Endocrinology ,Radionuclide therapy ,Medicine ,Clinical competence ,business ,Intensive care medicine - Abstract
This article presents updated diagnostic and therapeutic guidelines for the management of pancreatic neuroendocrine tumours (PNEN), proposed by the Polish Network of Neuroendocrine Tumours. The guidelines contain new data received in the years 2013-2016, which confirm previous recommendations, and have led to modification of previous guidelines or have resulted in the formulation of new guidelines. Biochemical and imaging (anatomical and functional) tests are of great importance in diagnostics, as well as histopathological diagnosis to determine the management of PNEN patients, but they must be confirmed by an immunohistochemical examination. PNEN therapy requires collaboration among the members a multidisciplinary team of specialists experienced in the management of these neoplasms. Surgery is the basic form of treatment in many cases. Further therapy requires a multidirectional procedure; therefore, the rules of biotherapy, peptide receptor radionuclide therapy, molecular targeted therapy, and chemotherapy are discussed.
- Published
- 2014
- Full Text
- View/download PDF
29. Biosimilars in Gastroenterology- An Important Moment in the Treatment of Inflammatory Bowel Diseases
- Author
-
Grażyna Rydzewska and Michal Lipinski
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,digestive, oral, and skin physiology ,medicine ,Inflammatory Bowel Diseases ,Biosimilar ,business ,Gastroenterology ,digestive system diseases - Abstract
Biosimilars in Gastroenterology- An Important Moment in the Treatment of Inflammatory Bowel Diseases
- Published
- 2016
- Full Text
- View/download PDF
30. Early changes in serum creatinine level and estimated glomerular filtration rate predict pancreatic necrosis and mortality in acute pancreatitis
- Author
-
A. Rydzewski, Michal Lipinski, and Grażyna Rydzewska
- Subjects
medicine.medical_specialty ,Creatinine ,Necrosis ,Hepatology ,Receiver operating characteristic ,business.industry ,Endocrinology, Diabetes and Metabolism ,Gastroenterology ,Renal function ,Retrospective cohort study ,medicine.disease ,chemistry.chemical_compound ,Endocrinology ,Elevated serum creatinine ,chemistry ,Internal medicine ,medicine ,Pancreatitis ,Acute pancreatitis ,medicine.symptom ,business - Abstract
Aim The aim of the study was to evaluate the significance of serum creatinine level (SCL) and estimated glomerular filtration rate (eGFR) measured in an early phase of acute pancreatitis (AP) for prediction of pancreatic necrosis (PNec) and mortality. Methods One hundred and forty-seven patients with AP were retrospectively reviewed in the study. Serum creatinine level and estimated glomerular filtration rate (calculated using the abbreviated Modification of Diet in Renal Disease equation) on admission and 48 h thereafter were analyzed for each patient. These parameters were compared with contrast-enhanced computed tomography images performed within 96 h from admission ( n = 103). Usefulness of SCL and eGFR for prediction of PNec and fatal outcome of AP was evaluated using a receiver operator characteristic curve analysis and comparison of average parameter values. Results We confirmed pancreatic necrosis in 41 (39.8%) of 103 patients using computed tomography examination. Both creatinine and estimated glomerular filtration rate measured on admission ( p p p = 0.001, p Moreover, serum creatinine level and eGFR measured on the 1st day proved to be a good predictor of fatal outcome. Both, mortality and presence of pancreatic necrosis were significantly higher in the group with elevated serum creatinine level and low eGFR values. Conclusions SCL and eGFR on admission are useful indicators of PNec and mortality.
- Published
- 2013
- Full Text
- View/download PDF
31. Immature granulocytes (IGS) at admission independently predict severe acute pancreatitis (AP)
- Author
-
Grażyna Rydzewska and Michal Lipinski
- Subjects
medicine.medical_specialty ,Hepatology ,Immature Granulocyte ,business.industry ,Endocrinology, Diabetes and Metabolism ,Internal medicine ,Gastroenterology ,medicine ,Acute pancreatitis ,medicine.disease ,business - Published
- 2017
- Full Text
- View/download PDF
32. Pancreatic cystic lesions in diabetes mellitus patients
- Author
-
Ewa Jozefik, Marta Sznurkowska, Martyna Rozek, Malgorzata Degowska, Grażyna Rydzewska, and Michal Lipinski
- Subjects
medicine.medical_specialty ,Cystic lesion ,Hepatology ,business.industry ,Endocrinology, Diabetes and Metabolism ,Internal medicine ,Diabetes mellitus ,Gastroenterology ,medicine ,business ,medicine.disease - Published
- 2018
- Full Text
- View/download PDF
33. Usefulness of IgG4 immunostaining of duodenal papilla biopsy specimens in diagnosis of autoimmune pancreatitis
- Author
-
Michal Lipinski, Anna Nasierowska-Guttmejer, Grażyna Rydzewska, Barbara Skrzydło-Radomańska, Malgorzata Degowska, and Mariusz Wyszkowski
- Subjects
Pathology ,medicine.medical_specialty ,Hepatology ,medicine.diagnostic_test ,business.industry ,Endocrinology, Diabetes and Metabolism ,Gastroenterology ,medicine.disease ,Major duodenal papilla ,Biopsy ,Medicine ,business ,Immunostaining ,Autoimmune pancreatitis - Published
- 2018
- Full Text
- View/download PDF
34. Mo1417 Serum Soluble Urokinase Plasminogen Activator Receptor (suPAR) and Systemic Inflammatory Response Syndrome (SIRS) in the Early Stage of Acute Pancreatitis (AP): Which Came First, the Chicken or the Egg?
- Author
-
Michal Lipinski, Grażyna Rydzewska, and Małgorzata Cicha
- Subjects
Hepatology ,Urokinase Plasminogen Activator ,business.industry ,Gastroenterology ,medicine.disease ,Systemic inflammatory response syndrome ,SuPAR ,Immunology ,medicine ,Acute pancreatitis ,Stage (cooking) ,Receptor ,business ,Chicken or the egg - Published
- 2016
- Full Text
- View/download PDF
35. Prognostic evaluation of severity of acute pancreatitis: not as black as it is painted
- Author
-
Grażyna Rydzewska and Michal Lipinski
- Subjects
medicine.medical_specialty ,Pathology ,Systemic disease ,business.industry ,Internal medicine ,Incidence (epidemiology) ,medicine ,Acute pancreatitis ,Inflammation ,medicine.symptom ,business ,medicine.disease ,Gastroenterology - Abstract
Acute pancreatitis (AP) is a systemic disease involving acute inflammation of the pancreatic gland due to premature activation of pancreatic proenzymes and different degree of damage to the adjacent tissues and sometimes more distant organs. An increasing trend is observed with the incidence of AP approximately 72 cases/100,000 inhabitants per year (1).
- Published
- 2017
- Full Text
- View/download PDF
36. Loss of neuronal 3D chromatin organization causes transcriptional and behavioural deficits related to serotonergic dysfunction
- Author
-
José P. López-Atalaya, Blazej Ruszczycki, Angel Barco, Victor Rovira, Grzegorz M. Wilczynski, Rafael Luján, Emilio Geijo-Barrientos, Bruno Contreras-Moreira, Michal Lipinski, Adriana Magalska, Satomi Ito, José L. Martínez-Hernández, Manuel Alcaraz-Iborra, and Román Olivares
- Subjects
Serotonin ,Transcription, Genetic ,Green Fluorescent Proteins ,General Physics and Astronomy ,Mice, Transgenic ,Biology ,Serotonergic ,General Biochemistry, Genetics and Molecular Biology ,Epigenesis, Genetic ,Euchromatin ,Histones ,Prosencephalon ,Heterochromatin ,Gene expression ,medicine ,Animals ,Cell Nucleus ,Neurons ,Multidisciplinary ,Behavior, Animal ,General Chemistry ,Anatomy ,Chromatin ,Mice, Inbred C57BL ,medicine.anatomical_structure ,Gene Expression Regulation ,nervous system ,Receptors, Serotonin ,Neuroscience ,Nucleus - Abstract
48 Pags.- 7 Figs. The definitive version, with suppl. Figs. and Supp. Tabls., is available at: http://www.nature.com/ncomms/index.html, The interior of the neuronal cell nucleus is a highly organized three-dimensional (3D) structure where regions of the genome that are linearly millions of bases apart establish sub-structures with specialized functions. To investigate neuronal chromatin organization and dynamics in vivo, we generated bitransgenic mice expressing GFP-tagged histone H2B in principal neurons of the forebrain. Surprisingly, the expression of this chimeric histone in mature neurons caused chromocenter declustering and disrupted the association of heterochromatin with the nuclear lamina. The loss of these structures did not affect neuronal viability but was associated with specific transcriptional and behavioural deficits related to serotonergic dysfunction. Overall, our results demonstrate that the 3D organization of chromatin within neuronal cells provides an additional level of epigenetic regulation of gene expression that critically impacts neuronal function. This in turn suggests that some loci associated with neuropsychiatric disorders may be particularly sensitive to changes in chromatin architecture., S.J. held a Juan de la Cierva contract from the Spanish Ministry of Economy and Competitiveness (MJNECO). J.L.A. held a postdoctoral contract (JAE DOC) from the Program Junta para la Ampliacion de Estudios’ co funded by the Fondo Social Europeo (FSE). AM. is supported by a posdoctoral fellowship from EU FP7 Project GA, N° 264173 (Bio Jmage). Research at ABs lab is supported by grants from MJNECO (SAF2O11 22855) and the Generalitat Valenciana (Prometeo/2012/005). Research at E.G.’s lab is supported by the grant BFU2O11 27326 and research at R.L.’s lab is supported by the CONSOLJDER grant C5D2008 00005 both given by MJNECO. Research at G.W.’s lab is supported by the grant POJG 01.01.02 00 008/08 from the European Regional Development Fund.
- Published
- 2014
- Full Text
- View/download PDF
37. Early changes in serum creatinine level and estimated glomerular filtration rate predict pancreatic necrosis and mortality in acute pancreatitis: Creatinine and eGFR in acute pancreatitis
- Author
-
Michal, Lipinski, A, Rydzewski, and G, Rydzewska
- Subjects
Adult ,Aged, 80 and over ,Male ,Adolescent ,Middle Aged ,Necrosis ,Pancreatitis ,Risk Factors ,Creatinine ,Acute Disease ,Humans ,Female ,Poland ,Tomography, X-Ray Computed ,Pancreas ,Aged ,Glomerular Filtration Rate ,Retrospective Studies - Abstract
The aim of the study was to evaluate the significance of serum creatinine level (SCL) and estimated glomerular filtration rate (eGFR) measured in an early phase of acute pancreatitis (AP) for prediction of pancreatic necrosis (PNec) and mortality.One hundred and forty-seven patients with AP were retrospectively reviewed in the study. Serum creatinine level and estimated glomerular filtration rate (calculated using the abbreviated Modification of Diet in Renal Disease equation) on admission and 48 h thereafter were analyzed for each patient. These parameters were compared with contrast-enhanced computed tomography images performed within 96 h from admission (n = 103). Usefulness of SCL and eGFR for prediction of PNec and fatal outcome of AP was evaluated using a receiver operator characteristic curve analysis and comparison of average parameter values.We confirmed pancreatic necrosis in 41 (39.8%) of 103 patients using computed tomography examination. Both creatinine and estimated glomerular filtration rate measured on admission (p 0.001, p 0.001 respectively) and 48 h later (p = 0.001, p 0.001 respectively) were significantly associated with the presence of pancreatic necrosis. Moreover, serum creatinine level and eGFR measured on the 1st day proved to be a good predictor of fatal outcome. Both, mortality and presence of pancreatic necrosis were significantly higher in the group with elevated serum creatinine level and low eGFR values.SCL and eGFR on admission are useful indicators of PNec and mortality.
- Published
- 2012
38. Immature granulocytes reflect severity in acute pancreatitis (AP) – A bird is known by its note
- Author
-
Michal Lipinski and Grażyna Rydzewska
- Subjects
Pathology ,medicine.medical_specialty ,Hepatology ,Immature Granulocyte ,business.industry ,Endocrinology, Diabetes and Metabolism ,Immunology ,Gastroenterology ,medicine ,Acute pancreatitis ,medicine.disease ,business - Published
- 2016
- Full Text
- View/download PDF
39. Mechanism for long-term memory formation when synaptic strengthening is impaired
- Author
-
Nicollette S. Maunganidze, Leszek Kaczmarek, Agnès Villers, Elżbieta Pyza, Laurence Ris, Elaine E. Irvine, Grace S. Pereira, Olivia Engmann, K. Peter Giese, Nina Thiede, Michal Lipinski, Márcio Flávio Dutra Moraes, Nikolay I. Medvedev, Magda Szymanska, Michael G. Stewart, and Kasia Radwanska
- Subjects
animal structures ,Memory, Long-Term ,Guanylate kinase ,Synaptogenesis ,Hippocampus ,Biology ,Synapse ,Mice ,Postsynaptic potential ,Ca2+/calmodulin-dependent protein kinase ,Animals ,Phosphorylation ,Genes, Immediate-Early ,PI3K/AKT/mTOR pathway ,Sirolimus ,Multidisciplinary ,Long-term memory ,TOR Serine-Threonine Kinases ,fungi ,Membrane Proteins ,Biological Sciences ,Cell biology ,Up-Regulation ,Synapses ,Calcium-Calmodulin-Dependent Protein Kinase Type 2 ,Neuroscience ,Disks Large Homolog 4 Protein ,Guanylate Kinases ,psychological phenomena and processes - Abstract
Long-term memory (LTM) formation has been linked with functional strengthening of existing synapses and other processes including de novo synaptogenesis. However, it is unclear whether synaptogenesis can contribute to LTM formation. Here, using α-calcium/calmodulin kinase II autophosphorylation-deficient (T286A) mutants, we demonstrate that when functional strengthening is severely impaired, contextual LTM formation is linked with training-induced PSD95 up-regulation followed by persistent generation of multiinnervated spines, a type of synapse that is characterized by several presynaptic terminals contacting the same postsynaptic spine. Both PSD95 up-regulation and contextual LTM formation in T286A mutants required signaling by the mammalian target of rapamycin (mTOR). Furthermore, we show that contextual LTM resists destabilization in T286A mutants, indicating that LTM is less flexible when synaptic strengthening is impaired. Taken together, we suggest that activation of mTOR signaling, followed by overexpression of PSD95 protein and synaptogenesis, contributes to formation of invariant LTM when functional strengthening is impaired.
- Published
- 2011
40. Mo1347 Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Patients With Acute Pancreatitis; Progress or ‘suPAR’ Revolution in Predicting Acute Pancreatitis Outcome
- Author
-
Andrzej Rydzewski, Grażyna Rydzewska, Alicja Rydzewska-Rosołowska, and Michal Lipinski
- Subjects
Urokinase ,medicine.medical_specialty ,Hepatology ,business.industry ,Gastroenterology ,medicine.disease ,Endocrinology ,SuPAR ,Internal medicine ,Medicine ,Acute pancreatitis ,In patient ,business ,Receptor ,Plasminogen activator ,medicine.drug - Published
- 2015
- Full Text
- View/download PDF
41. Fluid resuscitation in acute pancreatitis: Normal saline or lactated Ringer's solution?
- Author
-
Andrzej Rydzewski, Grażyna Rydzewska, Michal Lipinski, and Alicja Rydzewska-Rosołowska
- Subjects
Adult ,Male ,medicine.medical_specialty ,Resuscitation ,Ringer's Lactate ,Time Factors ,medicine.medical_treatment ,Sodium Chloride ,Severity of Illness Index ,Young Adult ,Risk Factors ,Retrospective Study ,Severity of illness ,Odds Ratio ,Humans ,Medicine ,Saline ,Aged ,Retrospective Studies ,Aged, 80 and over ,Chi-Square Distribution ,Pancreatitis, Acute Necrotizing ,business.industry ,Gastroenterology ,Retrospective cohort study ,General Medicine ,Odds ratio ,Middle Aged ,medicine.disease ,Surgery ,Logistic Models ,Treatment Outcome ,Pancreatitis ,Anesthesia ,Fluid Therapy ,Acute pancreatitis ,Female ,Poland ,Isotonic Solutions ,business ,Chi-squared distribution - Abstract
AIM: To investigate whether administration of Ringer’s solution (RL) could have an impact on the outcome of acute pancreatitis (AP). METHODS: We conducted a retrospective study on 103 patients [68 men and 35 women, mean age 51.2 years (range, 19-92 years)] hospitalized between 2011 and 2012. All patients admitted to the Department of Gastroenterology of the Central Clinical Hospital of the Ministry of Interior (Poland) with a diagnosis of AP who had disease onset within 48 h of presentation were included in this study. Based on the presence of persistent organ failure (longer than 48 h) as a criterion for the diagnosis of severe AP (SAP) and the presence of local complications [diagnosis of moderately severe AP (MSAP)], patients were classified into 3 groups: mild AP (MAP), MSAP and SAP. Data were compared between the groups in terms of severity (using the revised Atlanta criteria) and outcome. Patients were stratified into 2 groups based on the type of fluid resuscitation: the 1-RL group who underwent standard fluid resuscitation with a RL 1000 mL solution or the 2-NS group who underwent standard fluid resuscitation with 1000 mL normal saline (NS). All patients from both groups received an additional 5% glucose solution (1000-1500 mL) and a multi-electrolyte solution (500-1000 mL). RESULTS: We observed 64 (62.1%) patients with MAP, 26 (25.24%) patients with MSAP and 13 (12.62%) patients with SAP. No significant difference in the distribution of AP severity between the two groups was found. In the 1-RL group, we identified 22 (55.5%) MAP, 10 (25.5%) MSAP and 8 (20.0%) SAP patients, compared with 42 (66.7%) MAP, 16 (24.4%) MSAP and 5 (7.9%) SAP cases in the 2-NS group (P = 0.187). The volumes of fluid administered during the initial 72-h period of hospitalization were similar among the patients from both the 1-RL and 2-NS groups (mean 3400 mL vs 3000 mL, respectively). No significant differences between the 1-RL and 2-NS groups were found in confirmed pancreatic necrosis [10 patients (25%) vs 12 patients (19%), respectively, P = 0.637]. There were no statistically significant differences between the 1-RL and 2-NS groups in the percentage of patients who required enteral nutrition (23 patients vs 17 patients, respectively, P = 0.534). Logistic regression analysis confirmed these findings (OR = 1.344, 95%CI: 0.595-3.035, P = 0.477). There were no significant differences between the 1-RL and 2-NS groups in mortality and the duration of hospital stay (median of 9 d for both groups, P = 0.776). CONCLUSION: Our study failed to find any evidence that the administration of RL in the first days of AP leads to improved clinical outcomes.
- Published
- 2015
- Full Text
- View/download PDF
42. BISAP-eGFR could improve prediction of severity and mortality in acute pancreatitis. eGFR ? play the trump card
- Author
-
Michal Lipinski and Grażyna Rydzewska
- Subjects
medicine.medical_specialty ,Hepatology ,Receiver operating characteristic ,business.industry ,Endocrinology, Diabetes and Metabolism ,Gastroenterology ,Renal function ,medicine.disease ,Predictive value ,Internal medicine ,Cohort ,medicine ,Pancreatitis ,Acute pancreatitis ,In patient ,Intravascular volume depletion ,Intensive care medicine ,business - Abstract
Introduction: Early prediction of severity of acute pancreatitis (AP) by a simple system which includes clinical features would be very helpful as it may direct management and improve outcome. Certain components of different scores reflecting severe intravascular volume depletion can play an important role in accuracy of the method (but sensitivity and specificity of these scores are not at the desired level yet). Low eGFR (estimated glomerular filtration rate) is already known to be unfavorable prognostic parameter in AP, however it was never assessed as an element of multifactor score. Aim: The aim of this study is to determine whether replacing urea nitrogen (BUN) in bedside index of severity in acute pancreatitis (BISAP) score by eGFR (BISAP-eGFR score) improves prediction of severity and mortality in patients with AP. Methods: Cohort of 100 patients with AP were prospectively enrolled in the study. The BISAP and eGFR (abbreviated Modification of Diet in Renal Disease equation) were calculated using data from the first 24 h from admission. Severe AP was defined as the persistence of organ failure exceeding 48 hours. The predictive accuracy of the BISAP and BISAP-eGFR score was measured as the area under the receiver operating characteristic curve (AUC). Results: We evaluated a total of 100 consecutive patients with AP. Twenty of the 100 patients (20%) were considered severe AP. The best cutoff value of eGFR was 80 ml/min/1,73 m2. All 20 patients with severe pancreatitis had eGFR 25 mg/dL (BISAP score cut-off for BUN). Overall, 16% of the 100 evaluated patients had a BISAP score ≥3 while BISAP-eGFR score ≥ 3 was reported for 23% patients. A BISAP score ≥ 3 had a sensitivity, specificity, positive and negative predictive value of 65%, 96.1%, 81.2% and 91.3% respectively, with an accuracy of 87% comparing to 95.2%, 96.2%, 86.9% and 98.7% respectively for BISAP-eGFR score with an accuracy of 96%. The AUC for severity predicted by BISAP was 0.762 and by BISAP-eGFR score was 0.942. There were statistically significant trends for increasing severity (P
- Published
- 2014
- Full Text
- View/download PDF
43. Mo1326 BISAP-EGFR Could Improve Prediction of Severity and Mortality in Acute Pancreatitis. EGFR -Play the Trump Card
- Author
-
Grażyna Rydzewska and Michal Lipinski
- Subjects
medicine.medical_specialty ,Hepatology ,business.industry ,Gastroenterology ,medicine ,Acute pancreatitis ,Intensive care medicine ,business ,medicine.disease - Published
- 2014
- Full Text
- View/download PDF
44. Fluid resuscitation in acute pancreatitis: Normal saline or Ringer’s lactate - does it really make a difference?
- Author
-
Alicja Rydzewska-Rosołowska, Michal Lipinski, Grażyna Rydzewska, and Andrzej Rydzewski
- Subjects
medicine.medical_specialty ,Resuscitation ,Hepatology ,business.industry ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Gastroenterology ,medicine.disease ,Surgery ,Anesthesia ,medicine ,Acute pancreatitis ,Ringer's lactate ,business ,Saline - Published
- 2013
- Full Text
- View/download PDF
45. Tu1219 Cyst Fluid Neutrophil Gelatinase-Associated Lipocalin (NGAL) Concentration in the Differential Diagnosis of Pancreatic Cystic Lesions: A New Factor Enters the Scene
- Author
-
Grażyna Rydzewska, Janusz Milewski, Malgorzata Degowska, Marek Stobinski, and Michal Lipinski
- Subjects
Neutrophil gelatinase-associated lipocalin ,Pathology ,medicine.medical_specialty ,Cystic lesion ,Hepatology ,business.industry ,Gastroenterology ,Medicine ,Cyst ,Differential diagnosis ,business ,medicine.disease - Published
- 2013
- Full Text
- View/download PDF
46. Cyst fluid neutrophil gelatinase-associated lipocalin (NGAL) concentration in the differential diagnosis of pancreatic cystic lesions: a new factor enters the scene
- Author
-
Marek Stobinski, Grażyna Rydzewska, Janusz Milewski, Michal Lipinski, and Malgorzata Degowska
- Subjects
Neutrophil gelatinase-associated lipocalin ,Cystic lesion ,Pathology ,medicine.medical_specialty ,Hepatology ,business.industry ,Endocrinology, Diabetes and Metabolism ,Gastroenterology ,Medicine ,Cyst ,Differential diagnosis ,business ,medicine.disease - Published
- 2013
- Full Text
- View/download PDF
47. Sa1467 Early Changes in Urinary Neutrophil Gelatinase-Associated Lipocain Predict Severity and Mortality in Acute Pancreatitis
- Author
-
Alicja Rydzewska-Rosołowska, Michal Lipinski, Andrzej Rydzewski, and Grażyna Rydzewska
- Subjects
medicine.medical_specialty ,Hepatology ,business.industry ,Urinary system ,Internal medicine ,Gastroenterology ,Medicine ,Gelatinase ,Acute pancreatitis ,business ,medicine.disease - Published
- 2012
- Full Text
- View/download PDF
48. Urinary Neutrophil Gelatinase-Associated Lipocalin as an Early Predictor of Disease Severity and Mortality in Acute Pancreatitis
- Author
-
Andrzej Rydzewski, Grażyna Rydzewska, Alicja Rydzewska-Rosołowska, and Michal Lipinski
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pathology ,Time Factors ,Endocrinology, Diabetes and Metabolism ,Urinary system ,macromolecular substances ,Disease ,Urine ,Lipocalin ,Urinalysis ,Gastroenterology ,Severity of Illness Index ,Young Adult ,Endocrinology ,Disease severity ,Lipocalin-2 ,Predictive Value of Tests ,Internal medicine ,Proto-Oncogene Proteins ,Internal Medicine ,medicine ,Humans ,Prospective Studies ,Stage (cooking) ,Aged ,Aged, 80 and over ,Hepatology ,business.industry ,Middle Aged ,medicine.disease ,Prognosis ,Lipocalins ,Up-Regulation ,Pancreatitis ,ROC Curve ,Area Under Curve ,Cohort ,Acute Disease ,Acute pancreatitis ,Female ,business ,Biomarkers ,Acute-Phase Proteins - Abstract
OBJECTIVES In reference to our earlier publication, laboratory tests that reflect severe intravascular volume depletion can be used for predicting the severity of acute pancreatitis (AP). The aim of the study was to assess whether urinary level of neutrophil gelatinase-associated lipocalin (NGAL) could represent a useful marker of AP severity. METHODS We observed a cohort of 104 prospectively enrolled patients. The patients were classified into 3 groups: mild AP, moderately severe AP, and severe AP. Urine samples were collected on admission (NGAL-as) and during the first 24 hours (NGAL-first day) for examination of urinary level of NGAL concentrations from the first day. RESULTS Acute pancreatitis was considered severe in 16 (15%) patients, moderately severe in 25 (24%) patients, and mild in 63 (61%) patients.There were statistically significant trends for an increase in severity (P = 0.04, P = 0.003) and mortality (P < 0.031, P = 0.01) with raising NGAL-as and NGAL-first day concentrations, respectively. The areas under the curve for severity predicted by NGAL-as and NGAL-first day were 0.75 and 0.93, respectively. The areas under the curve for mortality prediction by NGAL-as and NGAL-first day were 0.980 and 0.92, respectively. CONCLUSIONS The urinary level of NGAL is a promising new diagnostic and prognostic factor for severe AP in an early stage of the disease.
49. Fluid resuscitation in acute pancreatitis: Normal saline or lactated Ringer's solution?
- Author
-
Lipinski M, Rydzewska-Rosolowska A, Rydzewski A, and Rydzewska G
- Subjects
- Adult, Aged, Aged, 80 and over, Chi-Square Distribution, Female, Fluid Therapy adverse effects, Fluid Therapy mortality, Humans, Isotonic Solutions adverse effects, Logistic Models, Male, Middle Aged, Odds Ratio, Pancreatitis diagnosis, Pancreatitis mortality, Pancreatitis, Acute Necrotizing diagnosis, Pancreatitis, Acute Necrotizing mortality, Poland, Retrospective Studies, Ringer's Lactate, Risk Factors, Severity of Illness Index, Sodium Chloride adverse effects, Time Factors, Treatment Outcome, Young Adult, Fluid Therapy methods, Isotonic Solutions administration & dosage, Pancreatitis therapy, Pancreatitis, Acute Necrotizing therapy, Sodium Chloride administration & dosage
- Abstract
Aim: To investigate whether administration of Ringer's solution (RL) could have an impact on the outcome of acute pancreatitis (AP)., Methods: We conducted a retrospective study on 103 patients [68 men and 35 women, mean age 51.2 years (range, 19-92 years)] hospitalized between 2011 and 2012. All patients admitted to the Department of Gastroenterology of the Central Clinical Hospital of the Ministry of Interior (Poland) with a diagnosis of AP who had disease onset within 48 h of presentation were included in this study. Based on the presence of persistent organ failure (longer than 48 h) as a criterion for the diagnosis of severe AP (SAP) and the presence of local complications [diagnosis of moderately severe AP (MSAP)], patients were classified into 3 groups: mild AP (MAP), MSAP and SAP. Data were compared between the groups in terms of severity (using the revised Atlanta criteria) and outcome. Patients were stratified into 2 groups based on the type of fluid resuscitation: the 1-RL group who underwent standard fluid resuscitation with a RL 1000 mL solution or the 2-NS group who underwent standard fluid resuscitation with 1000 mL normal saline (NS). All patients from both groups received an additional 5% glucose solution (1000-1500 mL) and a multi-electrolyte solution (500-1000 mL)., Results: We observed 64 (62.1%) patients with MAP, 26 (25.24%) patients with MSAP and 13 (12.62%) patients with SAP. No significant difference in the distribution of AP severity between the two groups was found. In the 1-RL group, we identified 22 (55.5%) MAP, 10 (25.5%) MSAP and 8 (20.0%) SAP patients, compared with 42 (66.7%) MAP, 16 (24.4%) MSAP and 5 (7.9%) SAP cases in the 2-NS group (P = 0.187). The volumes of fluid administered during the initial 72-h period of hospitalization were similar among the patients from both the 1-RL and 2-NS groups (mean 3400 mL vs 3000 mL, respectively). No significant differences between the 1-RL and 2-NS groups were found in confirmed pancreatic necrosis [10 patients (25%) vs 12 patients (19%), respectively, P = 0.637]. There were no statistically significant differences between the 1-RL and 2-NS groups in the percentage of patients who required enteral nutrition (23 patients vs 17 patients, respectively, P = 0.534). Logistic regression analysis confirmed these findings (OR = 1.344, 95%CI: 0.595-3.035, P = 0.477). There were no significant differences between the 1-RL and 2-NS groups in mortality and the duration of hospital stay (median of 9 d for both groups, P = 0.776)., Conclusion: Our study failed to find any evidence that the administration of RL in the first days of AP leads to improved clinical outcomes.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.